- In a 2016 paper, Vinod Khosla predicted that there would be some form of automation in medicine.
- But at the time, Khosla wrote that it would take decades for this to happen.
- But AI is already taking shape in some areas of the healthcare industry and is being used for diagnostics.
Vinod Khosla is known as a technology and venture capital visionary, and perhaps an investor like Nostradamus.
In a paper titled ’20-Percent Doctor Included’ & Dr. Algorithm: Speculations and Musings of a Technology Optimist,” written in 2016, Khosla predicted that the future of healthcare will include some form of automation. I am predicting.
“Within decades, data may transform diagnostics, initially up to 80 percent of the standard tasks of doctors and healthcare workers may be replaced by automated systems,” Khosla wrote.
Khosla was right about the automated system, but maybe the timing was a little off. What he predicted would take decades is taking shape just seven years after he wrote this paper.
As interest in AI spreads broadly, high-profile AI-powered healthcare startups are attracting the attention of VCs. Hippocratic AI, which recently raised $50 million in seed funding, plans to use machine learning to train AI models for use in medicine. Carta Healthcare, which uses AI to help healthcare providers cut costs, announced this month that it has raised $25 million. And New York-based startup Hyro has raised $20 million to replace outdated chatbots in healthcare with conversational AI.
By giving physicians access to better and more complete research data and knowledge, Kosra continued, “technological advances primarily amplify the capabilities of physicians,” which in turn “leads to better patient outcomes.” Connect,” he wrote.
The technology may not be fully developed yet, but it’s likely much sooner than Khosla envisioned this kind of advancement. AI is already used in some way in the medical system, for more mundane tasks like messaging and note-taking, but some doctors are using it to diagnose serious illnesses.
“Computers are far better than humans at organizing, recalling and synthesizing complex information and decisions,” Khosla said in a white paper. “This makes it far less error-prone and prejudiced than the good doctors at Harvard, much less the average (or median, if you’re a statistically-prone doctor) doctor, which is what I’m most concerned about here. There will be far fewer mistakes and prejudices.”
Khosla is known for making big leaps in areas where he sees great potential. He is an early investor in his OpenAI, the creator of his ChatGPT. And after leaving the storied venture capital firm Kleiner Perkins, where he spent nearly two decades as an investor, to form his own namesake company in 2004, Klean has long before many investors turned their attention to the field. I wanted to focus on technology.
Investing in clean tech wasn’t exactly fashionable at the time, but there are now a number of funds focused on clean tech and climate change tech, such as Chris Sacca’s Lower Carbon Capital.
“I’m happy to be on the cutting edge and take risks and keep it going for a very long time,” Khosla told Insider in 2021.
Watch Now: Top Insider Inc. Videos
Loading…
